CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Cytotools Ag Company Snapshot
Cytotools Ag operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cytotools Ag with three other pharmaceutical manufacturers in Europe: Vicore Pharma Holding AB of Sweden (2014 sales of 851,000.00 Swedish Kronor [US$97,745.86 ] ), Solon Eiendom ASA of Norway (1.77 million Norwegian Kroner [US$210,895.72 ] of which 93% was Soy-Based Products), and Immupharma PLC which is based in the United Kingdom (£184,815.00 [US$239,708.75 ] of which 100% was Pharmaceutical Research & Development).

Sales Analysis. Sales increased substantially in 2014: During the year ended December of 2014, sales at Cytotools Ag were 300,494.24 Euro (US$336.12 thousand). This is an increase of 501.0% versus 2013, when the company's sales were 50,000.00 Euro.
   
   
 
  Stock Performance Chart for Cytotools Ag
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 13.50
(Figures in Euro)
1 Week 9.5%   13 Weeks -12.5%  
4 Weeks 24.8%   52 Weeks 9.2%  
 
Cytotools Ag Key Data:
  Ticker: T5O Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2014 Sales 300,494
(Year Ending Jan 2015).
Employees: 1
  Currency: Euro Market Cap: 26,801,070
  Fiscal Yr Ends: December Shares Outstanding: 1,986,000
  Share Type: Inhaberstammaktien Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.